featured
Re-Cellularization via Electroporation Therapy of the Duodenum Combined With GLP-1 Receptor Agonist for Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Gastrointestinal Endoscopy
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Re-Cellularization via Electroporation Therapy of the duodenum combined with GPL-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes; 12 months results of a first-in-human study
Gastrointest. Endosc. 2024 Apr 29;[EPub Ahead of Print], CBE Busch, S Meiring, ACG van Baar, F Holleman, M Nieuwdorp, JJGHM BergmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.